SCHOTT achieved solid results in the Fiscal Year 2023/2024. The international technology group successfully navigated significant challenges, including a weak market environment in the home appliances sector, high energy and factor costs and increasing international competition. SCHOTT nearly maintained its global revenue at EUR 2.8 billion and achieved earnings before interest and taxes (EBIT) of EUR 400 million.
“Over the past year, we achieved steady financial results and further strengthened our equity, despite a challenging market environment. Additionally, our free cash flow increased considerably to EUR 148 million. Looking ahead, we aim to leverage this financial stability to drive innovation and growth in our key markets,” said Dr. Frank Heinricht, Chairman of the SCHOTT Management Board.
In FY 2023/2024, SCHOTT recorded a slight decline in revenue (-1 percent), while slightly increasing its equity ratio from 63 to 66 percent. The company is leveraging this financial strength to fund future investments in strategic growth and ambitious sustainability initiatives.
International expansion
The German company continued its international expansion with investments totaling approximately EUR 450 million in Europe, Asia, and the Americas to meet the demands of industry-specific global supply chains. Over the past year, SCHOTT inaugurated a new logistics center in Mitterteich, Germany, and opened a new production facility for optical precision components in Kulim, Malaysia, which also supplies high-end optics for the augmented reality (AR) sector.
SCHOTT Pharma also expanded its operations, increasing capacity for polymer syringes in Müllheim, Germany, among other initiatives. Additionally, SCHOTT Pharma opened a state-of-the-art production facility in Lukácsháza, Hungary, and celebrated the groundbreaking ceremony for a new factory in Jagodina, Serbia.
To read the full report click here.